About Jaft Biotech Private Limited
Data last updated:
Jaft Biotech Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 07 January 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24100DL2016PTC289405. Its GSTIN is 10AADCJ7014R1ZI (Bihar).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Naushaba Akbar and Md Javed Ashraf.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at R – 178/6 Third Floor Back Side Jogabai Extn. Jamia Nagar Okhla, New Delhi, Delhi, India – 110025.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.06 Cr, a growth of 16% compared to the previous year. For the same year it recorded a net profit of ₹35,476 (net margin 0.3%) and EBITDA of ₹1.26 Lakh (EBITDA margin 1.2%).
The current compliance status is marked as active non-compliant by the Registrar of Companies. For more details, the company can be reached via its website jaftbiotech.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressR – 178/6 Third Floor Back Side Jogabai Extn. Jamia Nagar Okhla, New Delhi, Delhi, India – 110025
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Jaft Biotech Private Limited
The main business activity of Jaft Biotech is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Jaft Biotech Private Limited FY 2025 filings available
Jaft Biotech Private Limited reported revenue of ₹1.06 Cr (up 16% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Jaft Biotech Private Limited
Revenue rose 16% in the latest year. EBITDA rose 135% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Jaft Biotech Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.26 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹35,476 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Jaft Biotech Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.2% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.3% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Jaft Biotech are in the company report.
Financial statements from FY 2016
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Jaft Biotech Private Limited
Jaft Biotech Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Health Essentials (India) Private Limited | ₹1.07 Cr (FY 2020) | •••• | •••• | -44.0% | •••• | Hyderabad, Telangana, India |
| Asterism Pharmaceuticals Private Limited | ₹1.07 Cr (FY 2025) | •••• | •••• | 29.0% | •••• | New Delhi, Delhi, India |
| Exact Medcare Private Limited | ₹1.07 Cr (FY 2025) | •••• | •••• | -26.0% | •••• | Delhi, India |
| Tanvir Pharma India Private Limited | ₹1.07 Cr (FY 2024) | •••• | •••• | -15.0% | •••• | New Delhi, Delhi, India |
| Clinical Sleep and Respiratory Solutions Private Limited | ₹1.06 Cr (FY 2024) | •••• | •••• | -3.0% | •••• | Bangalore, Karnataka, India |
| Jaft Biotech Private Limited this company | ₹1.06 Cr (FY 2025) | •••• | •••• | 16.0% | •••• | New Delhi, Delhi, India |
| Vetlink Pharma Private Limited | ₹1.06 Cr (FY 2025) | •••• | •••• | 0.0% | •••• | Lucknow, Uttar Pradesh, India |
| Ziven Lifesciences Limited | ₹1.06 Cr (FY 2022) | •••• | •••• | 47776.0% | •••• | Chandigarh, India |
| Lilyan Pharmaceuticals Private Limited | ₹1.06 Cr (FY 2024) | •••• | •••• | 1230.0% | •••• | Ulhasnagar, Maharashtra, India |
| Solitaire Biotech Pvt Ltd | ₹1.06 Cr (FY 2024) | •••• | •••• | -11.0% | •••• | Chandigarh, India |
| Astracure Lifesciences Private Limited | ₹1.06 Cr (FY 2025) | •••• | •••• | 41.0% | •••• | Siliguri, West Bengal, India |
Peers are the five companies nearest above and the five nearest below Jaft Biotech by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Jaft Biotech Private Limited
Jaft Biotech Private Limited is audited by DAYANAND JHA & CO for the financial year 2019.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| DAYANAND JHA & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Jaft Biotech Private Limited
Jaft Biotech has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Naushaba Akbar | Director | 07 Jan 2016 | 10 Years 9 Months | Current |
| Md Javed Ashraf | Director | 07 Jan 2016 | 10 Years 9 Months | Current |
| Rafat Pravin | Director | 07 Jan 2016 | 10 Years 9 Months | Current |
| Sabiha Khatoon | Director | 07 Jan 2016 | 10 Years 9 Months | Current |
Ownership and Shareholding of Jaft Biotech Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Jaft Biotech Private Limited
Jaft Biotech Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Jaft Biotech Private Limited
Employment history and EPFO contributions of people linked to Jaft Biotech.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Jaft Biotech Private Limited
Jaft Biotech Private Limited has 4 board changes on record since 2016: 4 appointments. The latest: Md Javed Ashraf was appointed as Director on 07 Jan 2016.
Credit Ratings, Litigation & Regulatory Alerts for Jaft Biotech Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Jaft Biotech Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Jaft Biotech Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Jaft Biotech Private Limited
Jaft Biotech has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AADCJ7014R1ZI | Bihar | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Jaft Biotech Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Jaft Biotech Private Limited
Jaft Biotech is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 07 January 2016 (10+ years old) and is registered under CIN U24100DL2016PTC289405.
Jaft Biotech reported revenue of ₹1.06 Cr for FY 2025 (up 16% YoY).
Jaft Biotech has 4 current directors:
- Naushaba Akbar - Director
- Md Javed Ashraf - Director
- Rafat Pravin - Director
- Sabiha Khatoon - Director
Jaft Biotech reported a net profit of ₹35,476 (net margin 0.3%) and EBITDA of ₹1.26 Lakh (EBITDA margin 1.2%) for FY 2025, as per its filed financial statements.
The GSTIN of Jaft Biotech is 10AADCJ7014R1ZI, registered in Bihar.
The CIN (Corporate Identification Number) of Jaft Biotech is U24100DL2016PTC289405. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Jaft Biotech was incorporated on 07 January 2016, making it 10+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Jaft Biotech by revenue are Health Essentials (India) Private Limited, Asterism Pharmaceuticals Private Limited, Exact Medcare Private Limited, Tanvir Pharma India Private Limited, Clinical Sleep and Respiratory Solutions Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Md Javed Ashraf was appointed as Director on 07 Jan 2016. Naushaba Akbar was appointed as Director on 07 Jan 2016. Rafat Pravin was appointed as Director on 07 Jan 2016. Jaft Biotech has 4 board changes on record in total.
Jaft Biotech can be reached through the website jaftbiotech.com. Its registered office is in New Delhi, Delhi, India.
The registered office of Jaft Biotech is at R – 1786 Third Floor Back Side Jogabai Extn. Jamia Nagar Okhla, New Delhi, Delhi, India – 110025.